Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

WHO agrees to buy up to 40 million vaccine doses from Pfizer


    Kyodo News

Geneva, Switzerland   /   Sat, January 23, 2021   /   02:00 pm
WHO agrees to buy up to 40 million vaccine doses from Pfizer The Pfizer/BioNTEch coronavirus disease (Covid-19) vaccine is pictured at The Michener Institute, in Toronto, Ontario on December 14, 2020. - Ontario, Canada's most populous province and one of the hardest hit by the pandemic, had 1,940 new cases and 23 deaths on Monday. The province is expected to give its next doses to nursing home workers as a priority, according to media reports. (AFP/CARLOS OSORIO / POOL)

The World Health Organization said Friday it has signed a purchase agreement for up to 40 million doses of the coronavirus vaccine developed by US pharmaceutical giant Pfizer as part of its initiative to provide global equitable access to COVID-19 vaccines.

Between the anticipated supply agreements for the Pfizer vaccine and ongoing work to approve an AstraZeneca/Oxford vaccine candidate, the UN health body expects to begin delivering COVID-19 vaccines by late February under an allocation framework designed to ensure access for low- and middle-income countries, the WHO said in a statement.

The Pfizer vaccine, jointly developed with German partner BioNTech SE, was the first vaccine to receive emergency use validation from the WHO since the outbreak of the novel coronavirus began.

Under an existing agreement, nearly 150 million doses of the AstraZeneca/Oxford vaccine candidate are ready to be shipped out to countries in need upon completion of the WHO's prequalification process to confirm the vaccine's safety and efficacy.

Earlier this week, WHO Director General Tedros Ghebreyesus had criticized vaccine manufacturers for seeking profit by enabling wealthier countries to buy up the available supply of vaccines.